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Summary.-The receptor patterns of cell suspensions from 29 cases of non-Hodgkin
lymphoma were correlated with the histology of the nodes from which the cells were
taken. Twenty-two were judged to be predominantly or largely B-cell, and because
of this preponderance these were divided by a method based on the distribution of
surface immunoglobulin and the expression of Fc and C3 receptors.
" Mature " B-cell and B-mixed tumours showing capping surface Ig with Fc and/or
C3 receptors correlated well with a nodular growth pattern, and consisted of what
Rappaport (1966) calls "poorly differentiated" lymphocytes equivalent to the "small
cleaved " cell as defined by Lukes and Collins (1975). Ten of the 14 patients in this
receptor category are alive between 12 and 30 months after diagnosis.
Receptor-silent and " immature " B-cell tumours with non-capping surface Ig
correlated predominantly with the Rappaport histiocytic lymphoma and Lukes and
Collins' large cleaved and large non-cleaved lymphomas, though these histological
categories also included a wide variety of other receptor types such as T-cell, Recep-
tor-overlap and the single true Macrophage tumour. Five of the 11 patients with
receptor-silent or immature B-cell tumours are alive between 7 and 15 months after
the diagnosis.
Diffuse mixed and diffuse poorly differentiated lymphocytic lymphomas in Rappa-
port's classification correlated poorly with receptors, mature and immature B-cell
tumours being equally represented.
THE first purpose of this paper is to
show how receptor studies on human
lymphomas may be used to identify the
cells present (Table I; Fig. 1). The second
is to assess the maturity ofthe B cell by a
number of cell surface markers, and the
third is to relate the surface markers to the
histology of the tumour. Previous at-
tempts to identify the cells present in
human lymphomas by surface marker
techniques (Brouet, Labaume and Selig-
mann, 1975; Cooper et al., 1975; Dorfman,
1975; Gajl-Peezalska, Bloomfield and
Sosin, 1975; Habeshaw and Stuart, 1975;
Jaffe etal., 1975; Huang etal., 1974; Peter,
Mackenzie and Glassy, 1974; Stuart and
Habeshaw, 1976; Smith et al., 1973) have
all shown that most non-Hodgkin lym-
phomas consist predominantly of B cells,
with a minority of T cells. A few are
derived from T cells, and those arising
from macrophages are distinctly un-
common. Tumours without B, T or
macrophage markers we call "receptor-
silent". Some authors have encountered
tumours in which the sum ofB and T cells
appears to exceed the total cell count.
This suggests simultaneous expression by
cells of both B and T characteristics,
named by us as " receptor overlap " (Lin
and Hsu, 1976; Habeshaw and Stuart,
1975; Murphy, 1975).
The receptors expressed at different
stages of B-cell differentiation in the
mouse have been well documented (Gel-
fand et al., 1974; Metcalf et al., 1975;CLASSIFICATION OF NON-HODGKIN LYMPHOMA
Ramasamy, Munro and Milstein, 1974;
Sidman and Unanue, 1975a, b). These
showed failure of surface Ig to " cap "
(aggregate at one pole of the cell) in the
most immature stages. As maturation
proceeds, the cells " cap " surface Jg and
express first Fc and then both Fc and C3
receptors. The plasma cells, or mature
secretory B cells, have inconsistent surface
markers, but contain intracytoplasmic Ig
(Corte et al., 1976). We and others have
found identical variations in the pattern
of surface Ig, Fe and C3 receptors in
human material such as normal peripheral
blood (Habeshaw and Young, 1975),
tonsil (Siegel, Grieco and Gupta, 1974),
and in lymphomas (Brouet et al., 1975;
Dorfman, 1975; Jaffe et al., 1975; Stuart
and Habeshaw, 1976; Habeshaw and
Stuart, 1975; Moscatelli, Bricarelli and
Quartino, 1976). It therefore seems
likely that the sequence of phenotype
change seen in mature mouse B-lymphoid
populations also occurs in man. If this
were true, the expression of surface Ig,
Fc and C3 receptors may be a means of
assessing cellular differentiation in human
B-cell neoplasms. In this paper we
propose a scheme of B-cell differentiation
in human non-Hodgkin lymphoma based
on the experimental and natural observa-
tions previously cited.
Tumours in which the B cells express
an undifferentiated receptor profile should
appearimmature histologicallyandbehave
aggressively clinically. The opposite
should apply to those tumours assessed as
well differentiated by surface markers.
In this paper we test this hypothesis in
25 tumours of B-cell or receptor-silent
type.
MATERIALS AND METHODS
The techniques employed are described in
outline only, since details have been reported
previously (Habeshaw and Young, 1975;
Stuart and Habeshaw, 1976; Dewar et al.,
1975).
Lymph-node cell suspensions.-Cell sus-
pensions in tissue culture medium were
prepared from lymph-node biopsy specimens.
Cells were not fractionated, and when via-
bility was < 60%, the suspension was
discarded. The material is not selected in
any other way than this, and represents a
continuous series of cases.
Antibodies: rabbit anti-sheep-red-cell and
rabbit anti-ox-red-cell antibodies.-IgM anti-
bodies were prepared by the i.v. immuniza-
tion of rabbits with ox or sheep erythrocyte
stroma according to themethodofKabatand
Mayer (1961). The IgM was obtained by
Sephadex G 200 gel chromatography in
0-1M Tris/HCl or glycine buffer at pH 8-0-8-4.
The first peak effluent contained most of the
IgM and most antibody activity by tray
titration.
Rabbit anti-ox-red-cell, anti-sheep-red-
cell, and anti-human-red-cell IgG antibodies
were made by conventional s.c. and i.p.
immunization ofrabbits, withthe appropriate
stroma. Purified IgG was obtained bysalting
out, dialysis against distilled water, and
batch chromatography on DEAE cellulose.
Rabbit anti-human-C3 and -C4 antisera
were used to demonstrate complement com-
ponents on the surface of sensitized red cells.
Formation of rosettes.-In 23 cases, par-
ticles were prepared, and rosettes formed
according to the standard methods described
by Habeshaw and Young (1975). In 6 cases,
Fc and C3 receptors were prepared using
rabbit anti-ox-RBC IgG (for Fc) and rabbit
anti-ox-RBC IgM + human R3 reagent (C3d
receptor) (Lachman, Hobart and Aston,
1973). Controls showed that results obtained
with sheep or ox red cells were comparable
for Fc and C3dreceptors. Aheavilysensitized
red cell is needed to detect all cells expressing
an Fe receptor. Mixed C and Fc receptors
were detected using human red cells sensitized
with rabbit anti-human-RBC IgG as pre-
viously described (Dewar et al., 1974).
Rosette counting is facilitated by the
addition of 01 ml of 0.01% solution of
acridine orange to the suspended rosettes
immediately before examination by fluores-
cence and phase-contrast microscopy (Bros-
toff, 1974).
Immunofluorescent staining. Antibodies
against human serum immunoglobulin were
obtained commercially. These included poly-
valent rabbit anti-human-immunoglobulin
(Nordic), FITC-coupled goat anti-rabbit
serum (Meloy, Nordic), and monospecific
antisera against heavy (IgM, IgA, IgG, IgD)
andlight (Kappa, Lambda)chainsofimmuno-
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globulins (Nordic, Meloy, Dakopats). Capp-
ing is a phenomenon dependent upon the
degree of cross-linking in the surface-Ig-anti-
Ig complex, and both temperature and time
of incubation. The conditions cited are
those which specifically favour the formation
of " caps" in normal B lymphoid tissue.
Increasing the times of incubation beyond
30 min can lead to cap shedding or interiori-
zation in normal lymphoid cells, and give rise
to an erroneous measurement of B lymphoid
cell numbers.
All antisera were centrifuged at 110,000 g
for 1 h before use, to remove aggregates ofTg.
They Awere then aliquoted in 0 1-ml quantities
and stored at -20°C for up to one month.
It should be emphasized that removal of
aggregated Ig from anti-human or anti-rabbit
immunoglobulin antisera by high speed
centrifugation is essential-otherwise B cells
as well as all other cells expressing the Fc
receptor will be stained, and any capping
w-hich occurs is then due to capping of Fc
receptors rather than capping of surface
Ig/anti Ig complex.
In 2 cases, the capacity of the tumour
cells to synthesize surface Ig following trypsi-
nization was assessed. Cells wxere treated
wvith 0-25%o trypsin (Armour) in PBS for
30 min at 37°C, to abolish surface Ig staining
entirely. After washing, the cells wvere
cultured in Medium 199 + 10% FCS for 24 h
and reassessed for presence of surface Ig, and
for cytoplasmic Ig.
Receptor terminology.-Using these
methods, the tumours are assigned to the
classes indicated in Tables I and II according
to the receptor pattern that predominates
over, the sum of all the others.
The term
" Mixed " implies that no single
class exceeded the sum of all the others. In
each of these cases, the wrord "mixed" is
preceded by the largest single cell class.
Receptor overlap.-The sensitization pro-
cedure controls described bv Dewar et al.
(1974) ensure that single cells expressing both
T and B characteristics are not overlooked.
Receptor silence. Cells failing to express
receptors by any of the methods outlined are
clearly ofunknown origin, and may be derived
from a metastatic carcinoma or sarcoma in a
lymph node. Where this has seemed likely
on clinical and histological grounds, the case
lhas been discarded, leaving, nonetheless,
some cases of histologicallyv undifferentiated
nieoplasms AN-itb an undoubted lymphomatous
look, and clinical findings appropriate to that
diagnosis.
Histological and cytological evaluation.
Tissue for histology wNAas taken from the slice
oflymph node biopsy next to that from which
the cell suspensions were made. Fixation
was in 10% formaldehyde in saline. Sections
were cut at 2-5 ,tm and stained with H. and
E., Gordon and Sweet's reticulin, Giemsa and
methyl green-Pyronin stains. The tumours
were classified using the Rappaport (1966)
and Lukes and Collins (1975) classifications.
Dabs of freshly cut lymph-node surface
and smears of the cell suspensions wiere
stained with May-Griinwald-Giemsa. As
xvell as giving increased cytological detail of
the cells, these techniques helped us judge
whether the cell population in the tissue
sections was equivalent to that in the
suspensions. Cytoplasmic immunoglobulin
content of the tumours w-as assessed by the
P.A.P. immunoglobulin technique of Taylor
and Burns (1974).
RESULTS
Receptor analysis
The results of the receptor analysis in
Table I show that 22/29 tumours were
predominantly B-cell. Nine of these 22
were classed as " B mixed " since they
contained an appreciable number of T
cells. Two showed receptor overlap, one
was a macrophage tumour and the last a
T-cell tumour.
Table II shows how the B lymphomas
can be further subdivided according to
their expression of surface Ig, Fc and C3
receptors and cytoplasmic Ig. Although
the origin of receptor-silent cells is
unknown, they are included, for coIn-
venience, with the B cells. The horizontal
line indicates an important division be-
tween tumours whose cells cap their
surface Ig (B3B4B5), called mature, and
those that do not (B1B2), regarded as
immature. Mature cells express receptors
for Fc and C3, whilst immature cells may
have no surface receptors or an Fc
receptor only, but never both Fc and C3.
Cases expressing only C3 receptors on
non-capping B cells were not seen in this
series, but may well occur. Capping of
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TABLE I.-Scheme of Receptor Expression in Non-Hodgkin Lymphoma
Characteristics
Category
B Lymphoma
T Lymphoma
Macrophage
Receptor-silent
Receptor overlap
E Rosette C3
_ +l_
++ _
++ +I
Phagocytosis
of
Fc Neutral Red Surface Ig
+1- _
++ ++
+
Number of
cases in
present
series
++ 22
1
1 _ 3
-+1- 2
+ Shown by a substantial number of lymph-node cells.
+ + Shown by the majority of lymph-node cells.
- Not shown by lymph-node cells.
TABLE II.-Sub-division of B-cell Lymphomas on the Basis of Surface Phenotype and
Functional Attributes of the Neoplastic Cells
Characteristics
Category
Receptor-silent
BI Immature
B2
B3
B4 Mature
B5J
Surface Ig
Non-capping
Non-capping
Capping
Capping
±
++
+
- Not shown by B cells.
+ Shown by a substantial number of B cells.
+ + Shown by the majority of B cells.
+ + + Shown by all B cells.
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FIG. 1.-Capping and non-capping surface-Ig-
bearing cells in 28 control lymph nodes (-)
and 22 B-cell or mixed lymphomas (0).
surface immunoglobulin (Fig. 1) occurs
more commonly in reactive than in
neoplastic nodes. Nevertheless, a higher
1 Number of
C3 Cytoplasmic Ig cases
3
5
3
++ - 9
+ ± 4
i +2+1
25
proportion ofnon-capping cells was found
in 2 highly reactive nodes with germinal
centres giving a B2 receptor profile.
Eighty per cent of the control lymph
nodes gave a mixed receptor pattern.
Comparison ofreceptorpatternswithRappa-
port's histological classification (1966)
The correlation of histology with the
B surface phenotype is shown in Table III.
Three ofthe 4 well differentiated lympho-
cytic lymphomas (Fig. 2) had cells that
were mature both morphologically and
by their expressed receptors. Two of
these are alive and in remission, the
third, also in remission, died of a myo-
cardial infarct. The fourth patient has
clinical features typical of chronic lym-
phocytic leukaemia but, unlike the other
three, his lymphocytes, in both blood and
lymph node biopsy, expressed an im-
mature receptor pattern.
.~~ o
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FIG. 2.-A well differentiated lymphocytic lymphoma (Rappaport). This is equivalent to Lukes
and Collins' small lymphocytic lymphoma. (H. and E. x 6001.
FiG. 3.-Cells from a nodule of poorly differentiated lymphocytic lymphoma (Rappaport). Nuclei
are slightly larger than those of well differentiated lymphocytes and have irregular outlines, often
with conspicuous clefts. These would be classified as Small Cleaved Follicular-centre cells by
Lukes and Collins. (H4. and E. x 600).
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FIG. 4. The cells of this poorly differentiated lymphocytic lymphoma are larger than those in
Figure 5, but maintain their irregular and cleaved nuclear outline. Nucleoli indistinct. In Lukes
and Collins' classification these would be termed Large Cleaved Follicular-centre cells. (H. and E.
x 600).
TABLE III.-Comparison of B Surface
Phenotype and Receptor Silence with
Rappaport's Classification
DM
DWL NPL DPL DH
Receptor-silent - 1 2
B1B2 1 1 2 4
B3B4B5 3 8 2 1
D Diffuse. W = Well differentiated.
N Nodular. P = Poorly differentiated.
L - Lymphocytic. M = Mixed.
H = Histiocytic or
undifferentiated.
In the nodular lymphomas, all were
poorly differentiated lymphocytic histo-
logically (Figs. 3 and 4), all but one
showed a mature receptor pattern and all
but one are alive and in remission. There
was a sequential change in the receptors
of the patient who died. At biopsy, the
lymph node cells were B3 (with a high
proportion T cells), but the blood B
lymphocytes were B2, with a receptor-
silent population of 10%. In spite of
histology that frequently indicates a good
prognosis, the patient had rapidly pro-
gressive disease and 10 days later the
receptor-silent population in the blood had
risen to 40%. The patient died soon after,
and autopsy showed a diffuse poorly
differentiated lymphocyticlymphoma. We
have since encountered a case offollicular
(nodular) lymphoma where the follicle-
centre cells were unusually large and there
were numerous mitotic figures. The
receptor profile was B2.
In the diffuse poorly differentiated and
diffuse mixed group there were tumours
with both mature and immature B
receptor patterns and poor correlation
with histology. The Rappaport " Histio-
cytic " group included 5 B-cell tumours
and 2 with receptor silence. Four of the
B-cell tumours had an immature receptor
pattern. One patient with a B1 tumour
became leukaemic terminally, with the
majority of his peripheral blood cells
receptor-silent.
Comparison of receptor patterns with Lukes
and Collins' classification (1975)
Table IV shows that 13/15 small-
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TABLE IV.-Comparison ofB Surface Phenotype and Receptor Silence with
Lukes and Collins' Classification
Receptor-silent
B1B2
B3B4B5
Small Small
lymphocyte cleaved
1 1
(follicular)
3* 10
(8 follicular)
(2 diffuse)
* This group includes one lymphoplasmacytoid tumour.
with the large non-cleaved tumours.
Large Large
cleaved non-cleaved
1
2
2
3
1 1
Immunoblastic sarcomas have been classified
._ I,M 1. _i..... ..... :;;. -.... .::I w..........--.. ....
FIG. 5. A histiocytic lymphoma (Rappaport). The cells are several times larger than small lym-
phocytes, and have vacuolated round or ovoid nuclei with one or more prominent nucleoli. These
are Large Non-cleaved cells of Lukes and Collins' classification. (H. and E. x 600).
lymphocyte and small-cleaved-cell tu-
mours consisted of mature B lymphocytes
as judged by receptors. Five of the 6
large non-cleaved tumours (Fig. 5) were
either immature or receptor-silent. Ifthe
large-cell groups (both cleaved (Fig. 4)
and non-cleaved (Fig. 5)) are taken
together, 8/10 show immature receptor
profiles or receptor silence. The large-cell
groups showed the greatest heterogeneity
of receptor expression. In contrast, the
small-cell tumours, with 2 exceptions,
expressed mature B-lymphocyte charac-
teristics.
DISCUSSION
These studies amply confirm that B-
cell tumours are the commonest of the
non-Hodgkin lymphomas. However, a
variable number of T cells was noted in
more mature tumours where frequently
neither T nor B cells predominated over
the sum of all others present. This mixed
pattern was noted especially in the
follicular or " nodular " lymphomas. It
is not known ifthis represents contamina-
tion of a neoplastic B population by
reactive T cells. One may speculate that
the physiological cooperation of T and B
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cells may be echoed in neoplasms and, if
so, the concept of " neoplastic " and
" reactive ' populations may be func-
tionally irrelevant.
Reservation must be expressed over
the small number of T- and macrophage-
derived tumours observed in this series.
Reliance on E rosetting by itself as a
method of identifying T cells is possibly
insufficient, and current techniques of
identifying macrophages ignore the pre-
cursor cell.
Salmon and Seligmann (1974) proposed
a scheme of B-lymphocyte development
in lymphoma, based upon the class of
secretory or surface-expressed immuno-
globulin. The classes of B lymphoma
proposed were Bo (B stem cells), B1
(virgin B lymphocyte), B2 (immunoblast),
B3 (memory B lymphocyte), B4 (plasma-
cytoid lymphocyte) and B5 (plasma cell).
They suggest that the course of develop-
ment oflymphoma involves the triggering
of a clone of responsive cells by antigen,
followed by a second oncogenic stimulus
which leads to irreversible proliferation of
" committed " B cells. In their classifica-
tion, the B1 tumours are represented most
commonly by CLL and the well differen-
tiated lymphocytic lymphoma group. The
B2 tumours are derived by division from
B1 cells, and the B2 component is the cell
found in poorly differentiated lymphocytic
lymphoma, Burkitt's and some histiocytic
lymphomas. The B or "memory " cell
has no equivalent in the lymphomas, but
from it is derived the lymphocytoid
plasma cell (B4) which secretes IgM. The
-final stage (B5) is the plasma cell.
The classification employed by us has
somesimilaritieswiththeirs,butallthesteps
in our proposed maturation sequence are
defined by receptor patterns demonstrated
by us and others in normal, experimental
and neoplastic lymphoid populations. Bi
and B2 tumours are those in which the
majority of cells have non-capping surface
Ig. B2 tumour cells have, in addition, an
Fc receptor. B3 and B4 tumour cells cap
their surface Ig and have both Fc and C3
receptors. B4 tumours differ from B3 by
having few Fc and C3 receptor-bearing
cells and sometimes showing cytoplasmic
Ig to a slight degree. Cytoplasmic Ig is
prominent in B5 tumours.
In our scheme, the primary division is
between B-cell tumours that cap their
surface Ig and those that do not. As
experimental work previously cited sug-
gests that this may be an indicator of
B-cell maturity, it seems justifiable to use
capping as a criterion to divide human B
lymphomas into "mature" and " im-
mature" groups. If this correlated with
histology and survival, receptor studies
might prove clinically useful.
133 B4 and B5 lymphomas correlate
well with a nodular growth pattern
(Rappaport, 1966) and with small cleaved
follicular-centre cells (Lukes and Collins,
1975). All have substantial numbers of
T lymphocytes in the affected node, giving
rise to a mixed rather than a B-predomi-
nant receptor pattern in half the patients
with nodular lymphomas. The similarity
of this pattern to the reactive lvmph
nodes should be noted. These findings
conflict with Rappaport's term
" poorly
differentiated " lymphocytic as 10/13
tumours of this cell type had mature
receptor profiles.
Table III shows that B-cell im-
maturity, as assessed by surface pheno-
type, correlates reasonably well with
histology showing large cleaved and non-
cleaved cells. This is in reverse order to
the theoretical basis of the Lukes and
Collins classification in which the small
cleaved cells are at the start of the
transformation sequence and, therefore,
should be less mature functionallv than
the large non-cleaved cells which are
thought to be the penultimate stage before
B-lymphocyte differentiation into plasma
cell. The large non-cleaved tumours are,
broadly speaking, equivalent to what
Rappaport calls histiocytic lymphomas.
This group shows the greatest hetero-
geneity of receptor expression, including
2 with receptor silence, 5 B-cell tumours
(4 immature, 1 mature), one with receptor
overlap and only one true histiocytic or
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macrophage tumour. Brouet et al. (1975)
reported 5 histiocytic lymphomas, 4 with
receptor silence and 1 with receptor
overlap.
This heterogeneity is reflected in the
varied clinical behaviour shown by these
lymphomas in 2 large retrospective series
Durant et al., 1975; Schein et al., 1974).
There is no way of separating the small
number of histiocytic lymphomas that do
well, even after local treatment, from the
many that are rapidly fatal. Identifica-
tion of distinct sub-groups by receptor
studies could therefore be very valuable.
It is noteworthy that receptor-overlap is
the only receptor class in which there have
been no deaths so far; one was a diffuse
histiocytic lymphoma, the other diffuse
mixed. Both were hard to classify histo-
logically and a search of retrospective
material is being undertaken for cases of
similar histology.
Neoplastic cells which appear receptor-
silent may develop surface immuno-
globulin following trypsinization and over-
night culture. This treatment is often not
possible with large-cell " histiocytic "
tumours whose cells in culture show poor
viability. Three ofour cases were receptor
silent at the time of initial biopsy, and 2
became so as their disease progressed.
All are dead within 2 years. This pattern
of receptor silence must be distinguished
from that seen in some patients with
diffuse, well differentiated lymphocytic
lymphoma and chronic lymphatic leu-
kaemia, whose small round morphologic-
ally mature lymphocytes, in both blood
and lymph nodes, fail to express surface
Ig, C3 and Fc receptors. These are
possibly "null" cells. We have en-
countered one such case, which after
trypsinization and overnight culture, ex-
pressed non-capping surface fluorescence
(Table III). In 2 similar cases, seen too
recently to be included in this series, the
cells remained receptor-silent after trypsi-
nization and overnight culture.
Correlation of receptors with clinical
survival is not possible with any certainty
in this small series, due to the short period
of follow-up in some cases. Nevertheless,
10/14 patients with " mature " receptors
are still alive (one died of a myocardial
infarct) compared with 5/11 whose re-
ceptors were " immature ".
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